共 50 条
- [34] Biological therapies for patients with Crohn's disease: More options mean less surgical interventions JOURNAL OF CROHNS & COLITIS, 2020, 14 : S288 - S289
- [36] Economic implications of biological therapies for Crohn’s diseaseReview of infliximab PharmacoEconomics, 2005, 23 : 875 - 888
- [40] Intestinal Tuberculosis Secondary to the Use of Biological Therapy: Can it Mimic Crohn's Disease? UNIVERSITAS MEDICA, 2021, 62 (01):